David Pacitti - 23 Jun 2026 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Reporting relationship: Director
Issuer ticker: OBIO
Reported as of: 23 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Jun 2026, 16:20:34 UTC
Prior SEC filing: 16 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Taylor, Attorney-in-Fact

Key filing fact

David Pacitti filed Form 4 for Orchestra BioMed Holdings, Inc. (OBIO) on 25 Jun 2026.

Key facts

This page summarizes David Pacitti's Form 4 filing for Orchestra BioMed Holdings, Inc. (OBIO).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 25 Jun 2026, 16:20.

Change

Previous filing in this sequence was filed on 16 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001722733 Primary reporting owner

Pacitti David

Relationship: Director
Address: C/O ORCHESTRA BIOMED HOLDINGS, INC., 150 UNION SQUARE DRIVE, NEW HOPE
Signature: /s/ Andrew Taylor, Attorney-in-Fact
Signature date: 25 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OBIO transaction

Common Stock, par value $0.0001 per share ("Common Stock")

Award

Transaction value
Shares: +17,327
Change %: +39%
Price: $0.000000^*
Shares after: 62,295
Date: 23 Jun 2026
Ownership: Direct
Footnotes: F1

OBIO transaction

Common Stock

Tax liability

Transaction value
Shares: -3,784
Change %: -6.1%
Price: $0.000000^*
Shares after: 58,511
Date: 24 Jun 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OBIO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +21,277
Change %
Price: $0.000000^*
Shares after: 21,277
Date: 23 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 21,277
Exercise price: $4.04
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on June 23, 2026 (the "Grant Date"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date.

Footnote F2

Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of RSUs. No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.

Footnote F3

The stock options will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date.